MCID: RLP003
MIFTS: 44

Relapsing Fever

Categories: Infectious diseases, Rare diseases

Aliases & Classifications for Relapsing Fever

MalaCards integrated aliases for Relapsing Fever:

Name: Relapsing Fever 12 56 52 42 14 69

Characteristics:

Orphanet epidemiological data:

56
relapsing fever
Inheritance: Not applicable; Age of onset: All ages;

Classifications:

Orphanet: 56  
Rare infectious diseases


External Ids:

Disease Ontology 12 DOID:13034
ICD10 33 A68 A68.9
ICD9CM 35 087 087.9
MeSH 42 D012061
Orphanet 56 ORPHA91547
MESH via Orphanet 43 D012061
UMLS via Orphanet 70 C0035021
ICD10 via Orphanet 34 A68.0 A68.1 A68.9
UMLS 69 C0035021

Summaries for Relapsing Fever

Disease Ontology : 12 A primary bacterial infectious disease that results_in infection, has material basis in Borrelia, which is transmitted_by tick or transmitted_by body louse.

MalaCards based summary : Relapsing Fever is related to tick-borne relapsing fever and louse-borne relapsing fever, and has symptoms including recurrent fevers An important gene associated with Relapsing Fever is MVK (Mevalonate Kinase), and among its related pathways/superpathways are Photodynamic therapy-induced AP-1 survival signaling. and Cellular Transformation by HTLV1. The drugs Artesunate and chloroquine have been mentioned in the context of this disorder. Affiliated tissues include b cells, brain and t cells, and related phenotype is immune system.

Related Diseases for Relapsing Fever

Diseases related to Relapsing Fever via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 120)
id Related Disease Score Top Affiliating Genes
1 tick-borne relapsing fever 12.5
2 louse-borne relapsing fever 12.4
3 trench fever 11.1
4 tick infestation 10.7
5 sodoku disease 10.7
6 pediculus humanus corporis infestation 10.7
7 multiple familial trichoepithelioma 10.7 CFH TNF
8 endosalpingiosis 10.6 CFH TNF
9 antigen-peptide-transporter 2 deficiency 10.6 CFH TNF
10 halal setton wang syndrome 10.6 CFH TNF
11 parametritis 10.6 CFH TNF
12 epstein-barr virus hepatitis 10.6 CRP TNF
13 euthyroid sick syndrome 10.6 CRP TNF
14 central nervous system leiomyosarcoma 10.6 CRP TNF
15 cicatricial lagophthalmos 10.6 CRP TNF
16 petrous apex meningioma 10.6 CRP TNF
17 polyarteritis nodosa 10.6 CRP TNF
18 signet ring cell adenocarcinoma 10.5 CRP TNF
19 islet cell tumor 10.5 CRP TNF
20 placental abruption 10.5 CRP TNF
21 functional gastric disease 10.5 CRP TNF
22 multiple epiphyseal dysplasia 10.5 TNF TNFRSF1A
23 retinitis pigmentosa 75 10.5 TNF TNFRSF1A
24 facial dermatosis 10.5 CRP TNF
25 megaloblastic anemia 10.5 CRP TNF
26 arthus reaction 10.5 CRP TNF
27 epb42-related hereditary spherocytosis 10.5 TNF TNFRSF1A
28 pericholangitis 10.5 CRP TNF
29 pulmonary plasma cell granuloma 10.5 CRP TNFRSF1A
30 tabatznik syndrome 10.5 MEFV TNF
31 craniometaphyseal dysplasia 10.5 MEFV TNF
32 myeloid sarcoma 10.5 CRP TNF
33 discitis 10.5 TNF TNFRSF1A
34 primary biliary cirrhosis 10.4 TNF TNFRSF1A
35 early congenital syphilis 10.4 CRP TNF
36 tetanus 10.4 MEFV TNF
37 plummer's disease 10.4 CRP TNF
38 residual stage corticosteroid-induced glaucoma 10.4 CRP TNF
39 peripheral nervous system disease 10.4 TNF TNFRSF1A
40 c1 inhibitor deficiency 10.4 CRP TNF
41 partial circumpapillary choroid dystrophy 10.4 CRP MEFV
42 amyloidosis nodular localized cutaneous 10.4 CRP MEFV
43 breast disease 10.4 CRP TNF
44 pyrimidine metabolic disorder 10.4 CRP MEFV
45 bardet-biedl syndrome 8 10.4 CRP TNF
46 acute neonatal citrullinemia type i 10.4 MEFV TNFRSF1A
47 acute megakaryoblastic leukemia without down syndrome 10.4 MEFV TNFRSF1A
48 myopathy 10.3 MEFV TNF
49 leigh syndrome with leukodystrophy 10.3 MEFV TNFRSF1A
50 familial cold-induced inflammatory syndrome 1 10.3 MEFV TNFRSF1A

Graphical network of the top 20 diseases related to Relapsing Fever:



Diseases related to Relapsing Fever

Symptoms & Phenotypes for Relapsing Fever

UMLS symptoms related to Relapsing Fever:


recurrent fevers

MGI Mouse Phenotypes related to Relapsing Fever:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.17 AKAP13 CFH CRP MEFV PURA TNF

Drugs & Therapeutics for Relapsing Fever

Drugs for Relapsing Fever (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 194)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Artesunate Approved Phase 4 88495-63-0 6917864 5464098
2
chloroquine Approved, Vet_approved Phase 4,Phase 2 54-05-7 2719
3
Primaquine Approved Phase 4,Phase 2 90-34-6 4908
4
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3 564-25-0 54671203
5
Capecitabine Approved, Investigational Phase 4 154361-50-9 60953
6
Irinotecan Approved, Investigational Phase 4,Phase 1 97682-44-5, 100286-90-6 60838
7
Ceftriaxone Approved Phase 4 73384-59-5 5479530 5361919
8
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
9
Itraconazole Approved, Investigational Phase 4 84625-61-6 55283
10
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 22916-47-8 4189
11
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
12
Interferon beta-1b Approved Phase 4,Phase 2 145155-23-3
13
Interferon beta-1a Approved, Investigational Phase 4 145258-61-3 6438354
14
Penicillin V Approved, Vet_approved Phase 4 87-08-1 6869
15
Azithromycin Approved Phase 4,Phase 3 83905-01-5 55185 53477736 447043
16
Camptothecin Experimental Phase 4,Phase 1 7689-03-4
17 Analgesics Phase 4,Phase 3,Phase 2,Early Phase 1
18 Analgesics, Non-Narcotic Phase 4,Phase 3,Phase 2,Early Phase 1
19 Anthelmintics Phase 4,Phase 2
20 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
21 Anti-Inflammatory Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
22 Anti-Inflammatory Agents, Non-Steroidal Phase 4,Phase 3,Phase 2,Early Phase 1
23 Antimalarials Phase 4,Phase 2,Phase 3
24 Antiparasitic Agents Phase 4,Phase 2,Phase 3
25 Antiprotozoal Agents Phase 4,Phase 2,Phase 3
26 Antirheumatic Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
27 Chloroquine diphosphate Phase 4,Phase 2 50-63-5
28 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1
29 Topoisomerase Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
30 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
31 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
32 Antitubercular Agents Phase 4
33 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2
34 Cytochrome P-450 Enzyme Inhibitors Phase 4,Phase 3,Phase 1
35 Cytochrome P-450 CYP1A2 Inhibitors Phase 4,Phase 3
36 Antimetabolites Phase 4,Phase 3,Phase 2
37 Antimetabolites, Antineoplastic Phase 4,Phase 3,Phase 2
38 Antineoplastic Agents, Phytogenic Phase 4,Phase 3,Phase 2,Phase 1
39 topoisomerase I inhibitors Phase 4,Phase 1
40 Fluoroquinolones Phase 4
41 Antifungal Agents Phase 4,Phase 3,Phase 2
42 Cytochrome P-450 CYP3A Inhibitors Phase 4,Phase 3,Phase 1
43 Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
44 Hormones Phase 4,Phase 3,Phase 2,Phase 1
45 Hormones, Hormone Substitutes, and Hormone Antagonists Phase 4,Phase 3,Phase 2,Phase 1
46 Hydroxyitraconazole Phase 4
47 Pharmaceutical Solutions Phase 4
48 Steroid Synthesis Inhibitors Phase 4,Phase 3
49 Lactams Phase 4
50 Adjuvants, Immunologic Phase 4,Phase 2,Phase 3

Interventional clinical trials:

(show top 50) (show all 74)

id Name Status NCT ID Phase Drugs
1 Comparison of Two Antimalarial Drugs Regimens in Patient With Plasmodium Vivax Malaria in Thailand Unknown status NCT01662700 Phase 4 Artesunate;Chloroquine
2 Phase II Trial Evaluating Irinotecan and Capecitabine Relapsed/Refractory Upper GI Tumours Completed NCT00220168 Phase 4 Irinotecan, Capecitabine
3 Comparison of Two Antimicrobial Therapy Duration for Spondylodiscitis Completed NCT00764114 Phase 4 antibiotic
4 Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric Fever Completed NCT01421693 Phase 4 Ceftriaxone;Gatifloxacin
5 Efficacy of Itraconazole as Secondary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation or Chemotherapy With Prior Invasive Fungal Infection Completed NCT01198236 Phase 4 Itraconazole
6 Febrile Urinary Tract Infection Randomized Short Treatment Trial Completed NCT00809913 Phase 4 short treatment (ciprofloxacin)
7 Evaluate Safety/Tolerability in Portuguese Participants With RRMS Transitioning From Current Therapy Recruiting NCT03177083 Phase 4 peginterferon beta-1a;interferon beta-1a;interferon beta-1b
8 Study of 5 and 10 Days Treatment With Penicillin Against Sore Throat Caused by Streptococci Recruiting NCT02712307 Phase 4 Phenoxymethylpenicillin
9 Scrub Typhus Antibiotic Resistance Trial Not yet recruiting NCT03083197 Phase 4 Doxycycline 7 days;Doxycycline 3 days;Azithromycin 3 days
10 Transition to Peginterferon Beta-1a (BIIB017) From Subcutaneous Interferon Therapy Withdrawn NCT02234869 Phase 4 Interferon Beta;BIIB017 (Peginterferon beta-1a)
11 Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia Unknown status NCT00020865 Phase 3 cefepime hydrochloride;levofloxacin
12 Post Exposure Treatment With Doxycycline for the Prevention of Relapsing Fever Completed NCT00237016 Phase 2, Phase 3 doxycycline treatment
13 Hyperthermia Combined Brachytherapy in CCU Completed NCT01474356 Phase 3
14 Combination Chemotherapy With or Without Hyperthermia Therapy in Treating Patients With Soft Tissue Sarcoma Completed NCT00003052 Phase 3 doxorubicin hydrochloride;etoposide;ifosfamide
15 Evaluation of Efficacy of Mesalamine in the Long-term Prevention of Diverticulitis Flares Completed NCT01120340 Phase 3 mesalamine
16 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
17 Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count Completed NCT00003805 Phase 3 piperacillin sodium;piperacillin-tazobactam;tazobactam sodium;vancomycin
18 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
19 To Study the Effect Of Single Infusions Of Amphotericin B Lipid Preparations in Treatment of Patients Of Kala Azar Completed NCT00876824 Phase 3 Amphotericin B Lipid emulsion;Liposomal Amphotericin B
20 Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase Completed NCT00991146 Phase 3 canakinumab
21 Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) in Relapse Ovarian Cancer Treatment Recruiting NCT01376752 Phase 3
22 Granulocyte Colony Stimulating Factor (G-CSF) After Salvage Chemotherapy in Refractory AML Recruiting NCT02427919 Phase 2, Phase 3 G-CSF
23 A Trial to Evaluate the Efficacy of Immunoglobulin Plus Steroid for Prevention of Coronary Artery Abnormalities in Taiwanese Refractory Kawasaki Disease (RAST Study) Recruiting NCT03200561 Phase 3 Prednisolone
24 Effects of Deep Regional Hyperthermia in Patients With Anal Carcinoma Treated by Standard Radiochemotherapy Recruiting NCT02369939 Phase 3 Mitomycin C;5-Fluorouracil
25 Nepal Undifferentiated Febrile Illness Trial Recruiting NCT02773407 Phase 3 Azithromycin;Co-trimoxazole
26 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Recruiting NCT03117751 Phase 2, Phase 3 Prednisone;Vincristine;Daunorubicin;Pegaspargase;Erwinase®;Rituximab;Cyclophosphamide;Cytarabine;Mercaptopurine;Dasatinib;Methotrexate;Blinatumomab;Ruxolitinib;Bortezomib;Dexamethasone;Doxorubicin;Etoposide;Clofarabine;Vorinostat;Idarubicin
27 Randomized Controlled Trial to Prevent Peritoneal Seeding in Gastric Cancer Recruiting NCT01683864 Phase 2, Phase 3 HIPEC with mytomycin and cisplatin
28 Empirical Versus Preemptive Antifungal Therapy Active, not recruiting NCT01288378 Phase 3 caspofungin acetate
29 Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed Aggressive Lymphoma Not yet recruiting NCT02238873 Phase 3 Pegfilgrastim
30 Cytoreductive Surgery and HIPEC in First or Secondary Platinum-resistant Recurrent Ovarian Epithelial Cancer Not yet recruiting NCT03220932 Phase 3 Chemotherapy and bevacizumab (CT-BEV)
31 A Study of Caspofungin, Liposomal Amphotericin B or the Combination of Both for Patients After Stem-Cell Transplantation Completed NCT00148148 Phase 2 caspofungin;liposomal amphotericin B
32 Extension of Prior Study Evaluating Safety and Tolerability of Two Doses of Betaseron® to Treat Relapsing-remitting Multiple Sclerosis Completed NCT00235989 Phase 2 Interferon beta 1b (Betaseron, BAY86-5046);Interferon beta 1b (Betaseron, BAY86-5046);Interferon beta 1b (Betaseron, BAY86-5046);Interferon beta 1b (Betaseron, BAY86-5046)
33 "LANK-2": Activated and Expanded NK Cell Immunotherapy Together With Salvage Chemotherapy in Children, Adolescents and Young Adults With Relapsed or Refractary Acute Leukemia Completed NCT02074657 Phase 2
34 Preventive Measures for Childhood-Onset Obsessive-Compulsive Disorder and Tic Disorders (PANDAS Subgroup) Completed NCT00001359 Phase 2 Penicillin or Placebo
35 Ph 2B/3 Tafenoquine (TFQ) Study in Prevention of Vivax Relapse Completed NCT01376167 Phase 2 Chloroquine 600mg;Chloroquine 300mg;Tafenoquine 50mg;Tafenoquine 100mg;Tafenoquine 300mg;Tafenoquine 600mg;Primaquine 15mg;Chloroquine 600mg (Part 2 );Chloroquine 300mg (Part 2 );Tafenoquine 300mg (Part 2);Primaquine 15mg (Part2 )
36 Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia Completed NCT01297972 Phase 1, Phase 2
37 Tocilizumab in Patients With Schnitzler's Syndrome Recruiting NCT03046381 Phase 2 Tocilizumab
38 Impact of CD34+ Cell Dose on Progression-free Survival Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL) Recruiting NCT02570542 Phase 2 Plerixafor;carmustine, etoposide, cytarabine, melphalan
39 Entospletinib and Obinutuzumab in Treating Patients With Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Non-Hodgkin Lymphoma Recruiting NCT03010358 Phase 1, Phase 2 Entospletinib
40 A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response Recruiting NCT02214381 Phase 2 Myocet;Cyclophosphamide;Paclitaxel
41 Vaccine Therapy in Curative Resected Prostate Cancer Patients Recruiting NCT01197625 Phase 1, Phase 2
42 Pilot Study of Hyperthermic Peritoneal Perfusion (HIPEC) for Adolescent and Young Adults With Desmoplastic Small Round Cell Tumor Active, not recruiting NCT01277744 Phase 2 Cisplatin
43 Bendamustine, Carboplatin and Dexamethasone (BCD) for Refractory or Relapsed Peripheral T-cell Lymphoma Active, not recruiting NCT02424045 Phase 2 BCD chemotherapy (Bendamustine, Carboplatin, Dexamethasone)
44 Heat-Activated Target Therapy of Local-Regional Relapse in Breast Cancer Patients Not yet recruiting NCT02850419 Phase 2 ThermoDox (Thermally Sensitive Liposomal Doxorubicin)
45 Management of Severe Chemotherapy-induced Neutropenia in Advanced Breast Cancer Not yet recruiting NCT03104595 Phase 2 EC-18
46 NM-IL-12 (rHuIL‐12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemotherapy Not yet recruiting NCT02544724 Phase 2
47 Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma Terminated NCT01944982 Phase 1, Phase 2
48 Flavopiridol in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma Terminated NCT00112723 Phase 1, Phase 2 alvocidib
49 Proof-of-Concept, Calcium Aluminosilicate Anti-Diarrheal (CASAD) for Treatment of Clostridium Difficile Infection Terminated NCT01570634 Phase 2 Calcium Aluminosilicate Anti-Diarrheal (CASAD)
50 HIFU Hyperthermia With Liposomal Doxorubicin (DOXIL) for Relapsed or Refractory Pediatric and Young Adult Solid Tumors Recruiting NCT02557854 Phase 1 Doxorubicin HCl liposomal injection

Search NIH Clinical Center for Relapsing Fever

Cochrane evidence based reviews: relapsing fever

Genetic Tests for Relapsing Fever

Anatomical Context for Relapsing Fever

MalaCards organs/tissues related to Relapsing Fever:

39
B Cells, Brain, T Cells, Testes, Nk Cells, Prostate, Bone

Publications for Relapsing Fever

Articles related to Relapsing Fever:

(show top 50) (show all 550)
id Title Authors Year
1
Relapsing fever causative agent in Southern Iran is a closely related species to East African borreliae. ( 28736193 )
2017
2
Development and optimization of an inA vitro cultivation protocol allows for isolation of Borrelia miyamotoi from patients with hard tick-borne relapsing fever. ( 28110053 )
2017
3
Relapsing fever in young refugees from East Africa. ( 28774320 )
2017
4
There Is a Method to the Madness: Strategies to Study Host Complement Evasion by Lyme Disease and Relapsing Fever Spirochetes. ( 28303129 )
2017
5
In Vitro Susceptibility of the Relapsing-Fever Spirochete Borrelia miyamotoi to Antimicrobial Agents. ( 28674060 )
2017
6
Host Immune Evasion by Lyme and Relapsing Fever Borreliae: Findings to Lead Future Studies for Borrelia miyamotoi. ( 28154563 )
2017
7
Plasmodium falciparum malaria co-infection with tick-borne relapsing fever in Dakar. ( 28077149 )
2017
8
Relapsing Fever ( 28722942 )
2017
9
Division of the genus Borrelia into two genera (corresponding to Lyme disease and relapsing fever groups) reflects their genetic and phenotypic distinctiveness and will lead to a better understanding of these two groups of microbes (Margos et al. (2016) There is inadequate evidence to support the division of the genus Borrelia. Int. J. Syst. Evol. Microbiol. doi: 10.1099/ijsem.0.001717). ( 28141502 )
2017
10
Transmission of Borrelia miyamotoi sensu lato relapsing fever group spirochetes in relation to duration of attachment by Ixodes scapularis nymphs. ( 28501504 )
2017
11
Louse-borne relapsing fever in Finland in two asylum seekers from Somalia. ( 27859692 )
2017
12
Louse-borne relapsing fever in a refugee from Mali. ( 28161771 )
2017
13
Epidemiological study of relapsing fever borreliae detected in Haemaphysalis ticks and wild animals in the western part of Japan. ( 28362864 )
2017
14
Borrelia sp. phylogenetically different from Lyme disease- and relapsing fever-related Borrelia spp. in Amblyomma varanense from Python reticulatus. ( 27342652 )
2016
15
Louseborne Relapsing Fever in Young Migrants, Sicily, Italy, July-September 2015. ( 26690334 )
2016
16
Lyme disease and relapsing fever Borrelia elongate through zones of peptidoglycan synthesis that mark division sites of daughter cells. ( 27506799 )
2016
17
Hard Tick Relapsing Fever Due to Borrelia Miyamotoi in a Child. ( 27626914 )
2016
18
Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever. ( 26918760 )
2016
19
Tick-Borne Relapsing Fever Outbreak Among a High School Football Team at an Outdoor Education Camping Trip, Arizona, 2014. ( 27430539 )
2016
20
Louseborne Relapsing Fever among East African Refugees, Italy, 2015. ( 26812354 )
2016
21
Chromosome and Linear Plasmid Sequences of a 2015 Human Isolate of the Tick-Borne Relapsing Fever Spirochete, Borrelia turicatae. ( 27417836 )
2016
22
Head Lice of Pygmies Reveal the Presence of Relapsing Fever Borreliae in the Republic of Congo. ( 27911894 )
2016
23
Borrelia miyamotoi: A human tick-borne relapsing fever spirochete in Europe and its potential impact on public health. ( 27100337 )
2016
24
Insights into Borrelia miyamotoi infection from an untreated case demonstrating relapsing fever, monocytosis and a positive C6 Lyme serology. ( 27412815 )
2016
25
An Alternative Strategy of Preventive Control of Tick-Borne Relapsing Fever in Rural Areas of Sine-Saloum, Senegal. ( 27430543 )
2016
26
Cyclic-di-GMP binding induces structural rearrangements in the PlzA and PlzC proteins of the Lyme disease and relapsing fever spirochetes: a possible switch mechanism for c-di-GMP-mediated effector functions. ( 27852620 )
2016
27
Tick-Borne Relapsing Fever, Southern Spain, 2004-2015. ( 27442975 )
2016
28
Louse-Borne Relapsing Fever with Meningeal Involvement in an Immigrant from Somalia to Italy, October 2015. ( 26938933 )
2016
29
Louse-borne relapsing fever among East African refugees in Europe. ( 26872415 )
2016
30
Where Are the Ticks? Solving the Mystery of a Tickborne Relapsing Fever Outbreak at a Youth Camp. ( 27188066 )
2016
31
Molecular identification of Borrelia genus in questing hard ticks from Portugal: Phylogenetic characterization of two novel Relapsing Fever-like Borrelia sp. ( 26976475 )
2016
32
Fourth case of louse-borne relapsing fever in Young Migrant, Sicily, Italy, December 2015. Mini Review Article. ( 27340042 )
2016
33
Epidemiological Study of Endemic Relapsing Fever in Hamadan Province, West of Iran. ( 28032111 )
2016
34
Tick-Borne Relapsing Fever in Dogs. ( 27353196 )
2016
35
Louse-borne relapsing fever - report of four cases in Switzerland, June-December 2015. ( 27188655 )
2016
36
Correction: Expression of the Tick-Associated Vtp Protein of Borrelia hermsii in a Murine Model of Relapsing Fever. ( 27074024 )
2016
37
Louse-Borne Relapsing Fever (Borrelia recurrentis) in a Somali Refugee Arriving in Italy: A Re-emerging Infection in Europe? ( 27149282 )
2016
38
Detection and Characterization of the Emerging Relapsing Fever Pathogen, Borrelia miyamotoi, from the Ixodes ricinus Tick in the Rural Trakya (Thrace) Region of Northwestern Turkey. ( 27788060 )
2016
39
Relapsing fever in asylum seekers from Somalia arriving in Belgium in August 2015. ( 27112219 )
2016
40
Host associations and genomic diversity of Borrelia hermsii in an endemic focus of tick-borne relapsing fever in western North America. ( 27832805 )
2016
41
Tick-Borne Relapsing Fever in Southwest Colorado: A Case Report. ( 27650717 )
2016
42
Louse-borne relapsing fever in a refugee from Somalia arriving in Belgium. ( 27356309 )
2016
43
Chromosome and Plasmids of the Tick-Borne Relapsing Fever Agent Borrelia hermsii. ( 27284141 )
2016
44
Borrelia miyamotoi: a widespread tick-borne relapsing fever spirochete. ( 25892254 )
2015
45
Louse-borne relapsing fever (Borrelia recurrentis) in an Eritrean refugee arriving in Switzerland, August 2015. ( 26290486 )
2015
46
Relapsing Fever Borreliae: A Global Review. ( 26593261 )
2015
47
Notes from the Field: Tickborne Relapsing Fever Outbreak at an Outdoor Education Camp - Arizona, 2014. ( 26086637 )
2015
48
Borrelia miyamotoi Disease: Neither Lyme Disease Nor Relapsing Fever. ( 26593262 )
2015
49
Case report: a retrospective serological analysis indicating human exposure to tick-borne relapsing Fever spirochetes in Texas. ( 25856342 )
2015
50
Louse-borne relapsing fever (Borrelia recurrentis) in asylum seekers from Eritrea, the Netherlands, July 2015. ( 26250069 )
2015

Variations for Relapsing Fever

Expression for Relapsing Fever

Search GEO for disease gene expression data for Relapsing Fever.

Pathways for Relapsing Fever

GO Terms for Relapsing Fever

Biological processes related to Relapsing Fever according to GeneCards Suite gene sharing:

(show all 12)
id Name GO ID Score Top Affiliating Genes
1 inflammatory response GO:0006954 9.67 CRP MEFV TNF TNFRSF1A
2 regulation of cell proliferation GO:0042127 9.65 PURA TNF TNFRSF1A
3 positive regulation of I-kappaB kinase/NF-kappaB signaling GO:0043123 9.58 AKAP13 TNF TNFRSF1A
4 intrinsic apoptotic signaling pathway in response to DNA damage GO:0008630 9.51 TNF TNFRSF1A
5 establishment of protein localization to plasma membrane GO:0090002 9.49 TNF TNFRSF1A
6 regulation of tumor necrosis factor-mediated signaling pathway GO:0010803 9.46 TNF TNFRSF1A
7 extrinsic apoptotic signaling pathway via death domain receptors GO:0008625 9.43 TNF TNFRSF1A
8 negative regulation of inflammatory response GO:0050728 9.33 MEFV MVK TNFRSF1A
9 negative regulation of lipid storage GO:0010888 9.32 CRP TNF
10 positive regulation of ceramide biosynthetic process GO:2000304 9.26 TNF TNFRSF1A
11 death-inducing signaling complex assembly GO:0071550 8.96 TNF TNFRSF1A
12 regulation of establishment of endothelial barrier GO:1903140 8.62 TNF TNFRSF1A

Sources for Relapsing Fever

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....